Autres langues Athersys, Inc.

Actions

ATHXQ

US04744L2051

Marché Fermé - OTC Markets Autres places de cotation 21:42:02 26/04/2024			Varia. 5j.	Varia. 1 janv.
0,0044 ^USD	0,00%		-2,22%	-78,00%

05/04	Athersys, Inc. annonce des changements au sein de son conseil d'administration	CI
03/04	Healios K.K. (TSE:4593) a conclu l'acquisition de la quasi-totalité des actifs d'Abt Holding Company, Advanced Biotherapeutics, Inc, Athersys, Inc (OTCPK:ATHX.Q), ReGenesys BVBA et ReGenesys, LLC.	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

North American Morning Briefing : Stock Futures Edge Lower Ahead of PPI Inflation Gauge	11/04
Athersys : Acquisition/Asset Disposal - Form 8-K	05/04
Athersys, Inc. Announces Board Changes	05/04
Healios Concludes Purchase of Athersys Assets, Becoming Sole Owner of MultiStem IP	04/04
North American Morning Briefing : Focus Turns to -2-	04/04
Healios K.K. completed the acquisition of Substantially all assets of Abt Holding Company, Advanced Biotherapeutics, Inc, Athersys, Inc. (OTCPK:ATHX.Q), ReGenesys BVBA and ReGenesys, LLC .	03/04
Final DIP Financing Approved for Athersys, Inc.	13/02
Bidding Procedure Approved for Athersys, Inc.	13/02
Healios' Ischemic Stroke Trial Data Published in JAMA Neurology Journal	18/01
Interim DIP Financing Approved for Athersys, Inc.	12/01
Motion for Joint Administration Approved for Athersys, Inc.	12/01
Healios Steps In as Primary Bidder and Lender for Athersys’s Asset Sale Amidst Bankruptcy	10/01
Motion for Asset Sale Filed by Athersys, Inc.	06/01
Motion for Joint Administration Filed by Athersys, Inc.	06/01
Athersys, Inc. Filed for Bankruptcy	05/01
Healios K.K. entered into an asset purchase agreement to acquire Substantially all assets of ABT Holding Company, Advanced Biotherapeutics, Inc, Athersys, Inc. (OTCPK:ATHX.Q), ReGenesys BVBA and ReGenesys, LLC for $2.8 million.	05/01
Athersys, Inc. Announces Termination of Maia Hansen as Chief Operating Officer, Effective from December 31, 2023	22/12
Athersys, Inc. Announces Termination of Daniel A. Camardo as Chief Executive Officer, Effective from December 31, 2023	22/12
Athersys Reports Third Quarter 2023 Financial Results and Business Highlights	17/11
Athersys Extends Near Term Liquidity with Proceeds from Warrant Inducement and Global ARDS License with Healios to Explore Strategic Alternatives	17/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Athersys, Inc.

Actions

ATHXQ

US04744L2051

Autres langues

Filtres